Member Info for JustHereForHemo

Now hold on davie.... lets not rule anything out.... as long as everyone is an adult :P Oh... yea I guess that does rule out a pdiddy party...

Top left of your screen, there is a very small expandable box that has a bug icon then lse and WEB1/2/3/4/5 etc.. Click on it and you can see lots about the site (redis and mysql), they expose enough schema for a hacker to have a field day, I really hope they have good protection against sql injection....

What on earth does this mean for TFI Fridays???? I have had food in there lots, really good ribs, hope they stay open!!

Funding had been an issue for the past 6 years, when have they ever had more than a few million on hand?

It's the very reason they have built their own in house labs for production of CAR-T and CBR. It's the reason their preference is a non profit charity MD Anderson for clinical trials, it's the reason they morh balled HuPHEC.

They need 10s if not 100s of millions to move forward, we are at that point, sscs is back with the tired old funding attack. Shocking, but predictable and boring. Even Stu is not that sad to try that now, with less than 5% headroom they are not raising the millions they need via placings. JV, partnership, licensing etc as stated by Stu is the only workable option, which means yep, funding is an issue but the update resolving it is going to be huge.

There is literally 0 chance of Hemogenyx taking this to completion without some sort of licencing / JV etc. Trials take years and cost 100s of millions which is why small pharma often sell early. But who knows maybe your right, what I can say is in every meeting, every zoom, every interview when this has been discussed Vlad has always said HEMO-CAR-T is for sale at the right price and he will licence when he gets the right offer and he anticipates that will come with early clinical results. I have posted alot of licencing deals for pre-clinical / Phase 1 CAR-T treatments. If there are no complications/clinical holds I would be gobsmacked if this is not sold in Phase 1. This is the cash cow thats going to pay for CDX and CBR development.

The patients they select for this trial will be as otherwise healthy as possible, someone gets injection of HEMO-CAR-T and they die within the first 30 days for ANY reason (other than say getting shot or hit by a bus...) I am sure there would be a clinical hold to rule out CAR-T. To be clear none of us are expecting any issues. The point is, at this point we don't really care if it works, the IND enabling studies proved it works, MD Anderson were convinced enough to head hunt this trial. It's likely to be licenced long before clinical trials complete, in fact it has too be, trials cost 100s of millions, just need to prove it does not kill people first.

Efficiency is NOT the primary concern, that they can test in primates and mice. The primary purpose is SAFETY. That's what they need to prove and they absolutely will know within days if not first few weeks if the patient has a reaction to the treatment.

It will be very obvious if this has negative side effects as there will be a clinical hold if that happens. If not? If they move on to patient 2?......

Https://www.adcreview.com/clinical-trials-update/bristol-myers-squibb-acquires-orum-therapeutics-orm-6151-program/

A different trial just starting with MD Anderson......... phase 1 also....

TL;DR version -

Traders going to trade, SP COULD drop back, if thats more important to you than potentially selling just before news drops on funding/trials start then you should sell. If making sure you dont miss out on trials/funding RNS is more important then ignore the traders and do your own thing.

Reality is last week (even before) we had X new faces here with some on Twitter, all suddenly Hemo experts and posting away. Coincidently there was alot of buying at the same time and SP went up, strangely these accounts are now posting about OTHER shares and there are buys that correspond with that too.... There are traders and RNS chasers, they are experts in every share they invest with for the whole 5 mins they are invested. To many of these people the idea of staying invested in any one company more than 24 hrs is disgusting and repugnant. But you cant attract actual investors without also attracting traders, the key is to let the traders come but instead of attacking which is what happens here, speak to the investors who may have arrived at the same time as the traders but are more inclined to stay invested after the next RNS drops on AIM.

the question about the funding RNS that Stu promised? looking at it logically it HAS to be CDX, HuPHEC? Nope, CBR? No the patent is not sorted, funding there will likely be BARDA etc related. HEMO-CAR-T? Nope, not this close to trials, madness to link funding to a candidate about to start trials. That leaves CDX and the RNS 2 weeks ago which is obviously related and unlocks that 3rd party buy in. 2 weeks..... Literally 2 weeks.... Its Vlad, does anyone REALLY believe he had a funding contract sitting ready to sign the second the RNS dropped? Sounds like he had some agreement but its also likely the ball only got rolling with the lawyers AFTER the RNS. Stu made it sound like it was imminent, well it has not dropped yet which is more realistic, does not make it any less real or imminent NOW 2 weeks later.

If you trust MD Anderson the number 1 site in USA for these trials then trials will start soon, when the first injection starts a very real clock starts, where EVERYTHING is on the line. A humans life will be on the line and they will live or die, how long will ACTUAL pharma investors stay away? Will Vlad/Hemo/MD Anderson/Prevail make a big deal about patient 1?

The sell off past few days is not surprising, those who in hindsight say it was inevitable or they should have sold etc are saying so in hindsight after NO RNS dropped. Unless those posting are insiders and KNEW no RNS would land then its pure and utter guess work and speculation. Traders care about buying the next news whatever share it is, investors care about not being out when the next news lands here. But yea, the waiting is very annoying!

@Gra2am, RE your question about Monkey Pox and CBR, an extract:

"Exemplary viral vectors include, but are not limited to, adenovirus vectors {e.g., adenovirus 5), adeno-associated virus (AAV) vectors {e.g., AAV2, 3, 5, 6, 8, 9), retrovirus vectors (MMSV, MSCV), lentivirus vectors (e.g., HIV-1, HIV-2), gammaretrovirus vectors, herpes virus sectors te.g., HSV1, HSV2), alphavirus vectors {e.g., SFV, SIN, VEE, MI), flavivirus (e.g., Kunjin, West Nile, Dengue virus), rhabdovirus vectors {e.g., rabies virus, VSV), measles virus vector {e.g., MV-Edm), Newcastle disease virus vectors, poxvirus vectors {e.g., VV), measles virus, and picomavirus vectors {e.g., Coxsackievirus)."

MPox falls under the poxvirus family so certainly is a disease the company considered to be within the remit of CBR.

Quick summary - I am sure will be hidden very soon! Those who attempt to push it off screen do so for a reason...

Anyway - CAR-T This is the big one, READ THE RNS....

Its with MD Anderson - Number 1 for these trials in the USA - THEY APPROACHED HEMOGENYX and asked to take the trial THEY have leapfrogged PENN and are moving faster. They are non profit and the RNS says Trials to start IMMINENTLY. Before first treatment there needs to be a patient selected and CAR-T prepared, we might already be in that process but its probably another few weeks away.

CAR-T is now well established and a quick google will demonstrate worth with many early pre-clinical and phase 1 licencing deals available. Upfront + milestones here is 100s of millions -> 1bn (Note Hemo mCap is around 20m....)

CBR -> Multiple strands with Government involvement and atleast one 3rd party with Lvl 3 facilities to test live viruses, we are wayyyyyy overdue an update here with conferences lined up (REALLY SEE RNS FOR THIS...)

CDX - We thought it was on the shelf.... Looks like it has been re-engineered, the RNS 2 weeks ago the culmination of alot of work. The suggestion from many who profess to have contacts is that non-dilutive funding will be attached to something that is not CAR-T, the patent for CBR is not complete and probably needs amended so that leaves CDX, which makes this RNS very significant.

So to keep HT happy - RNS chasers..... Is an RNS guaranteed tomorrow? Nope, is it guaranteed any day at 7am? Nope. Is it guaranteed this week or next? Nope. The ONLY thing we can be sure of is MD Anderson are running a trial for Hemo, its in THEIR court and timetable not Vlads. At the current mCap Hemogenyx is valued at a fraction of all other CAR-T oncology companies in clinical trials. No guarantees it will re-rate to meet its peers.... But WHY not? What makes Hemo so special that it will never re-rate, will never see the value every other company does in this field? Is HEMO-CAR-T for AML worth 50 times less because it came from Hemo vs Eli?

This share IS undervalued, it WILL rerate. ACCORDING TO THE NUMBER ONE TROLL STU A NON DILUTIVE FUNDING RNS IS COMING.

Hmm, what do you call someone who spends years invested in a company, completely free to sell at any time, but instead opts to spend years attacking that company?

Bounds to be a name for it...

Quick summary - I am sure will be hidden very soon! Those who attempt to push it off screen do so for a reason...

Anyway - CAR-T This is the big one, READ THE RNS....

Its with MD Anderson - Number 1 for these trials in the USA - THEY APPROACHED HEMOGENYX and asked to take the trial THEY have leapfrogged PENN and are moving faster. They are non profit and the RNS says Trials to start IMMINENTLY. Before first treatment there needs to be a patient selected and CAR-T prepared, we might already be in that process but its probably another few weeks away.

CAR-T is now well established and a quick google will demonstrate worth with many early pre-clinical and phase 1 licencing deals available. Upfront + milestones here is 100s of millions -> 1bn (Note Hemo mCap is around 20m....)

CBR -> Multiple strands with Government involvement and atleast one 3rd party with Lvl 3 facilities to test live viruses, we are wayyyyyy overdue an update here with conferences lined up (REALLY SEE RNS FOR THIS...)

CDX - We thought it was on the shelf.... Looks like it has been re-engineered, the RNS 2 weeks ago the culmination of alot of work. The suggestion from many who profess to have contacts is that non-dilutive funding will be attached to something that is not CAR-T, the patent for CBR is not complete and probably needs amended so that leaves CDX, which makes this RNS very significant.

So to keep HT happy - RNS chasers..... Is an RNS guaranteed tomorrow? Nope, is it guaranteed any day at 7am? Nope. Is it guaranteed this week or next? Nope. The ONLY thing we can be sure of is MD Anderson are running a trial for Hemo, its in THEIR court and timetable not Vlads. At the current mCap Hemogenyx is valued at a fraction of all other CAR-T oncology companies in clinical trials. No guarantees it will re-rate to meet its peers.... But WHY not? What makes Hemo so special that it will never re-rate, will never see the value every other company does in this field? Is HEMO-CAR-T for AML worth 50 times less because it came from Hemo vs Eli?

This share IS undervalued, it WILL rerate. ACCORDING TO THE NUMBER ONE TROLL STU A NON DILUTIVE FUNDING RNS IS COMING.

It's my stubborn refusal to let trolls own this site without challenge. I am STILL waiting for you to say one single negative word to Stu who is the source of the financing RNS news. And lol, pot calling kettle black! You have been here as long as me, EXCEPT as a shareholder I am consistent and posting why I'm invested and why this is a good buy. You have been posting negative bs for years, it's really really sad, like I'm sure you have your reasons but it's sad.

Oh bless, some people not appreciate positivity? My goodness, I wonder why lol 😆 but trolling and attacking is just swell and acceptable, don't worry I know positivity is not welcome here, the fact it seems to annoy the trolls encourages me. Good to know who sold up, MrIndia and myself will be having a good laugh when this pays out :-D 😀 😍

We HAVE been here before correct! Increased volume, anticipated news and a bit of a dip as Fridays traders move on having expended all 5 mins of their attention span. Middle of February.... Thats how far you have to go back to find ANY tick up of any of the 20/50/100 Volume Weighted moving averages OVER HALF A YEAR of downward movement... And it finally moved up Thursday/Friday. 7 months.... IMO its safe to say bottom is in.

When have we seen increased volume, build up and interest before? Before the CDX news (ended up being bad news and SP tanked but it surged before), we saw it spike up to 7p in the build up to FDA IND approval. So yea we HAVE been here before, we have seen what happens when traders start to look at Hemo, and its usually north, hopefully this time we go north, stay north and get GOOD news!

HT, are you trying to compete with Pumpkin for 1 line snarky irrelevant posts? She is miles ahead to be fair... As for blaming todays drop on traders? Err... yea? That goes without saying, traders bought thursday friday, were all over LSE posting, and today they have sold and gone silent, honestly dude, that is not rocket science, why do you think the SP dropped? Because the MMs went to Harrys 40th birthday and got drunk and hit the wrong button?

Quick summary - I am sure will be hidden very soon! Those who attempt to push it off screen do so for a reason...

Anyway - CAR-T This is the big one, READ THE RNS....

Its with MD Anderson - Number 1 for these trials in the USA - THEY APPROACHED HEMOGENYX and asked to take the trial THEY have leapfrogged PENN and are moving faster. They are non profit and the RNS says Trials to start IMMINENTLY. Before first treatment there needs to be a patient selected and CAR-T prepared, we might already be in that process but its probably another few weeks away.

CAR-T is now well established and a quick google will demonstrate worth with many early pre-clinical and phase 1 licencing deals available. Upfront + milestones here is 100s of millions -> 1bn (Note Hemo mCap is around 20m....)

CBR -> Multiple strands with Government involvement and atleast one 3rd party with Lvl 3 facilities to test live viruses, we are wayyyyyy overdue an update here with conferences lined up (REALLY SEE RNS FOR THIS...)

CDX - We thought it was on the shelf.... Looks like it has been re-engineered, the RNS 2 weeks ago the culmination of alot of work. The suggestion from many who profess to have contacts is that non-dilutive funding will be attached to something that is not CAR-T, the patent for CBR is not complete and probably needs amended so that leaves CDX, which makes this RNS very significant.

So to keep HT happy - RNS chasers..... Is an RNS guaranteed tomorrow? Nope, is it guaranteed any day at 7am? Nope. Is it guaranteed this week or next? Nope. The ONLY thing we can be sure of is MD Anderson are running a trial for Hemo, its in THEIR court and timetable not Vlads. At the current mCap Hemogenyx is valued at a fraction of all other CAR-T oncology companies in clinical trials. No guarantees it will re-rate to meet its peers.... But WHY not? What makes Hemo so special that it will never re-rate, will never see the value every other company does in this field? Is HEMO-CAR-T for AML worth 50 times less because it came from Hemo vs Eli?

This share IS undervalued, it WILL rerate. ACCORDING TO THE NUMBER ONE TROLL STU A NON DILUTIVE FUNDING RNS IS COMING.

Pumpkin the other site is precisely because of this B277 $417, lets keep the BS and trolling here ty!

Ah! I see, your not aloud to have a guess? Are you not the one who often says "Never", "Nope", "None" etc?

I am not sure why your ego is more dominant than your intelligence?

For sure there was no guarantee of an RNS this morning, but lets face it one is due pretty soon, IMO 1-5 weeks for start of Trials, + Stu predicted an RNS on non-dilutive funding (Funny you have NEVER criticised him, not once, despite his prediction, I thought there would be an update on CBR, HE predicted a massive non-dilutive funding package!!??? But nope, your silent about him...)

People are not going to know that news is imminent here unless people actually talk about it, and whilst none of us actual LTHers want the next day RNS chasers we DO want investors and sadly there is no version of Twitter that is ONLY investors, and no version of this site where you can ONLY talk to potential investors and not traders...

SP is actually considerably higher than it was last week, and in no small part that will be due to traders, some who will yes sell on news. So what would you prefer? EVERYONE stayed super silent, nobody shared anything and the SP stayed at 1.2p and when news comes we still stay at 1.2p?

Is it so difficult to comprehend that small cap shares like this are driven by sentiment, something Vlad does not get and nor do you it seems... If people can appreciate the potential, can appreciate the upside and more importantly see that they dont have to wait that long to see that upside and see the short term opportunity then they will invest. So is is just personal petty grievances you have or have you sold up and just prefer SP to stay low?